PL337577A1 - Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor - Google Patents

Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor

Info

Publication number: PL337577A1
Authority: PL; Poland
Prior art keywords: thiazolydinone; glucosidaze; diabetes; inhibitor; alpha
Prior art date: 1997-06-18

Application number

PL98337577A

Other languages

English (en)

Inventor

Stephen Alistair Smith

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-18

Filing date

1998-06-15

Publication date

2000-08-28

1997-06-18 Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en

1998-03-27 Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en

1998-06-15 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-08-28 Publication of PL337577A1 publication Critical patent/PL337577A1/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Fodder In General (AREA)

PL98337577A 1997-06-18 1998-06-15 Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor PL337577A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9712865.6A GB9712865D0 (en)	1997-06-18	1997-06-18	Novel method of treatment
GBGB9806708.5A GB9806708D0 (en)	1998-03-27	1998-03-27	Novel method

Publications (1)

Publication Number	Publication Date
PL337577A1 true PL337577A1 (en)	2000-08-28

Family

ID=26311746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL98337577A PL337577A1 (en)	1997-06-18	1998-06-15	Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor

Country Status (24)

Country	Link
EP (1)	EP0975343A1 (fr)
JP (1)	JP2001523271A (fr)
KR (1)	KR20010013845A (fr)
CN (1)	CN1274282A (fr)
AP (1)	AP9901720A0 (fr)
AR (2)	AR014881A1 (fr)
AU (1)	AU8799998A (fr)
BG (1)	BG103966A (fr)
BR (1)	BR9810186A (fr)
CA (1)	CA2294134A1 (fr)
CO (1)	CO4940453A1 (fr)
DZ (1)	DZ2519A1 (fr)
EA (1)	EA200000040A1 (fr)
IL (1)	IL133138A0 (fr)
MA (1)	MA26510A1 (fr)
NO (1)	NO996270L (fr)
NZ (1)	NZ501345A (fr)
OA (1)	OA11631A (fr)
PE (1)	PE89199A1 (fr)
PL (1)	PL337577A1 (fr)
SK (1)	SK179499A3 (fr)
TR (1)	TR199903072T2 (fr)
UY (1)	UY25051A1 (fr)
WO (1)	WO1998057635A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
HRP20010773B1 (en)	1999-04-23	2005-06-30	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
US20030045553A1 (en)	2001-04-04	2003-03-06	Bussolari Jacqueline C.	Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
JP4590158B2 (ja)	2001-04-04	2010-12-01	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	グルコース再吸収阻害剤およびレチノイド−ｘ受容体モジュレーターを含んで成る併用療法
FR2832930A1 (fr) *	2001-12-03	2003-06-06	Lipha	Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP2004067575A (ja) *	2002-08-06	2004-03-04	Yaizu Suisankagaku Industry Co Ltd	糖尿病治療薬効果促進剤
CN101121004B (zh) *	2006-08-08	2010-07-21	鲁南制药集团股份有限公司	含有胰岛素增敏剂和米格列醇的药物组合物
CN101584705B (zh) *	2008-05-24	2010-10-27	鲁南制药集团股份有限公司	一种治疗糖尿病及其并发症的药物组合物
CN101584688B (zh) *	2008-05-24	2010-11-10	鲁南制药集团股份有限公司	一种治疗糖尿病及其并发症的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06510286A (ja) *	1991-08-26	1994-11-17	ファルマシア・アンド・アップジョン・カンパニー	３−グアニジノプロピオン酸およびピオグリタゾン、グリベンクラミドまたはグリメピリドを含有する医薬組成物
US5917052A (en) *	1994-09-28	1999-06-29	Shaman Pharmaceuticals, Inc.	Hypoglycemic agent from cryptolepis
TW438587B (en) *	1995-06-20	2001-06-07	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes

1998
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/fr not_active Ceased
- 1998-06-15 PL PL98337577A patent/PL337577A1/xx unknown
- 1998-06-15 JP JP50375699A patent/JP2001523271A/ja not_active Ceased
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 CN CN98806319A patent/CN1274282A/zh active Pending
- 1998-06-15 EA EA200000040A patent/EA200000040A1/ru unknown
- 1998-06-15 EP EP98939513A patent/EP0975343A1/fr not_active Withdrawn
- 1998-06-15 SK SK1794-99A patent/SK179499A3/sk unknown
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/ko not_active Withdrawn
- 1998-06-15 IL IL13313898A patent/IL133138A0/xx unknown
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/pt not_active IP Right Cessation
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/xx unknown
- 1998-06-15 CA CA002294134A patent/CA2294134A1/fr not_active Abandoned
- 1998-06-17 MA MA25121A patent/MA26510A1/fr unknown
- 1998-06-17 AR ARP980102885A patent/AR014881A1/es unknown
- 1998-06-17 AR ARP980102882A patent/AR013352A1/es unknown
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/fr active
- 1998-06-18 CO CO98034648A patent/CO4940453A1/es unknown
- 1998-06-18 UY UY25051A patent/UY25051A1/es not_active Application Discontinuation
- 1998-06-18 PE PE1998000536A patent/PE89199A1/es not_active Application Discontinuation
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
1999
- 1999-12-08 BG BG103966A patent/BG103966A/bg unknown
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
- 1999-12-17 NO NO996270A patent/NO996270L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2001523271A (ja)	2001-11-20
WO1998057635A1 (fr)	1998-12-23
UY25051A1 (es)	2000-09-29
KR20010013845A (ko)	2001-02-26
NO996270D0 (no)	1999-12-17
SK179499A3 (en)	2000-11-07
CO4940453A1 (es)	2000-07-24
AR014881A1 (es)	2001-04-11
MA26510A1 (fr)	2004-12-20
OA11631A (en)	2004-11-22
EA200000040A1 (ru)	2000-08-28
IL133138A0 (en)	2001-03-19
CA2294134A1 (fr)	1998-12-23
PE89199A1 (es)	1999-10-23
NZ501345A (en)	2001-10-26
EP0975343A1 (fr)	2000-02-02
BR9810186A (pt)	2000-08-08
TR199903072T2 (xx)	2000-07-21
AR013352A1 (es)	2000-12-27
AU8799998A (en)	1999-01-04
BG103966A (bg)	2000-07-31
AP9901720A0 (en)	1999-12-31
DZ2519A1 (fr)	2003-02-01
NO996270L (no)	1999-12-17
CN1274282A (zh)	2000-11-22

Publication	Publication Date	Title
AP9901719A0 (en)	1999-12-31	Treatment of diabetes with thiazolidinedione and metormin
ZA962768B (en)	1996-11-13	Benzonitriles and benzofluorides
EG21712A (en)	2002-02-27	Treatment of insulin resistance
PL341709A1 (en)	2001-04-23	Structural combination of rubber and metal
AP9901718A0 (en)	1999-12-31	Treatment of diabetes with rosiglitazone and insulin
IL133138A0 (en)	2001-03-19	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
PL338127A1 (en)	2000-09-25	Method of treating diabetes with thiazolydinone and sulphonylurea
IL133137A0 (en)	2001-03-19	Treatment of diabetes with thiazolidinedione and sulphonylurea
IL133907A0 (en)	2001-04-30	Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
HUP9800146A3 (en)	2000-06-28	Thalidomide-derivatives and use of them
AU7688998A (en)	1998-12-11	Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
AU4107797A (en)	1998-12-11	Compounds for the treatment and prevention of diabetes
HK1025263A (en)	2000-11-10	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
GB9618290D0 (en)	1996-10-16	Treatment of diabetes
GB9721978D0 (en)	1997-12-17	Treatment of depression
HUP0002668A3 (en)	2001-12-28	Treatment of diabetes with thiazolidinedione and metformin
IL121656A0 (en)	1998-02-08	Diagnosis prevention and treatment of diabetes
GB9609897D0 (en)	1996-07-17	Treatment of diabetes
PL338862A1 (en)	2000-11-20	Derivatives of 2-oxypyroimidin-4-one and 2-oxypyroimidin-4-thione
GB9408914D0 (en)	1994-06-22	Treatment and pophylaxis of infarction
GB9700481D0 (en)	1997-02-26	Assay and method of treatment
HUP0002669A3 (en)	2001-12-28	Treatment of diabetes with thiazolidinedione and sulphonylurea
GB2322623B (en)	2001-09-05	Treatment of liquid
GB9815149D0 (en)	1998-09-09	Treatment of diabetes
GB9812314D0 (en)	1998-08-05	Treatment of diabetes